Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.
Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, Singh A, Peelay Z, Chakraborty S, Jadhav M, Alone M, Bhagyavant P, Kolkur M, Srinivas S, Das S, Roy S, Mandal T, Dsouza H, Saha S, Rai R, Srikanth A, Shah D, Khan A, Muthuluri H, Kumar A, Agarwal A, Rajpurohit A, Goli VB, Sekar A, Mantri A, Kanteti APK, Majumdar S, Khaddar S, Shenoy R, Elamarthi P, Rathnasamy N, Kashyap L, Abraham G, Booma N, Simha V, Chaukar D, Pai P, Nair S, Laskar S, Nawale K, Naidu P, Salian S, Shelar P, Raulo R, Dhumal SB, Prabhash K. Noronha V, et al. Among authors: mathrudev v. Eur J Cancer. 2024 Mar;200:113560. doi: 10.1016/j.ejca.2024.113560. Epub 2024 Jan 20. Eur J Cancer. 2024. PMID: 38306841 Clinical Trial.
Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized study.
Noronha V, Patil V, Menon N, Kalra D, Singh A, Shah M, Goud S, Jobanputra K, Nawale K, Shah S, Chowdhury OR, Mathrudev V, Jogdhankar S, Singh MY, Singh A, Adak S, Sandesh M, Arunkumar R, Kumar S, Mahajan A, Prabhash K. Noronha V, et al. Among authors: mathrudev v. Med Oncol. 2023 Dec 21;41(1):26. doi: 10.1007/s12032-023-02234-z. Med Oncol. 2023. PMID: 38129716 Clinical Trial.
Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation - a randomised trial.
Patil V, Noronha V, Menon N, Mathrudev V, Bhattacharjee A, Nawale K, Parekh D, Banavali S, Prabhash K. Patil V, et al. Among authors: mathrudev v. Lancet Reg Health Southeast Asia. 2023 Feb 24;12:100162. doi: 10.1016/j.lansea.2023.100162. eCollection 2023 May. Lancet Reg Health Southeast Asia. 2023. PMID: 37384061 Free PMC article.
Audit of screen failure in 15 randomised studies from a low and middle-income country.
Parekh D, Patil VM, Nawale K, Noronha V, Menon N, More S, Goud S, Jain S, Mathrudev V, Peelay Z, Dhumal S, Jogdhankar S, Prabhash K. Parekh D, et al. Among authors: mathrudev v. Ecancermedicalscience. 2022 Nov 23;16:1476. doi: 10.3332/ecancer.2022.1476. eCollection 2022. Ecancermedicalscience. 2022. PMID: 36819805 Free PMC article.
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A, Peelay Z, Alone M, Pathak S, Mahajan A, Kumar S, Purandare N, Agarwal A, Puranik A, Pendse S, Reddy Yallala M, Sahu H, Kapu V, Dey S, Choudhary J, Krishna MR, Shetty A, Karuvandan N, Ravind R, Rai R, Jobanputra K, Chaturvedi P, Pai PS, Chaukar D, Nair S, Thiagarajan S, Prabhash K. Patil VM, et al. Among authors: mathrudev v. J Clin Oncol. 2023 May 1;41(13):2350-2361. doi: 10.1200/JCO.22.00980. Epub 2023 Jan 27. J Clin Oncol. 2023. PMID: 36706347 Clinical Trial.
RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.
Patil V, Noronha V, Joshi A, Menon N, Mathrudev V, Bhattacharjee A, Chandrasekharan A, Vallathol D, Dsouza H, Srinivas S, Mandal T, Chaturvedi P, Chaukar D, Pai P, Nair S, Thiagrajan S, Laskar S, Nawale K, Babanrao Dhumal S, Tambe R, Banavali S, Prabhash K. Patil V, et al. Among authors: mathrudev v. Oral Oncol. 2022 May;128:105816. doi: 10.1016/j.oraloncology.2022.105816. Epub 2022 Mar 31. Oral Oncol. 2022. PMID: 35367787 Clinical Trial.
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin.
Menon NS, Noronha V, Patil VM, Joshi A, Bhattacharjee A, Kalra D, Laskar SG, Mathrudev V, Nawale K, Bhelekar AS, Prabhash K. Menon NS, et al. Among authors: mathrudev v. Cancer Med. 2022 Nov;11(21):3939-3948. doi: 10.1002/cam4.4715. Epub 2022 Mar 28. Cancer Med. 2022. PMID: 35343648 Free PMC article. Clinical Trial.
Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trial.
Menon N, Patil V, Noronha V, Joshi A, Bhattacharjee A, Satam BJ, Mathrudev V, Ghosh Laskar S, Prabhash K. Menon N, et al. Among authors: mathrudev v. Oral Oncol. 2021 Nov;122:105517. doi: 10.1016/j.oraloncology.2021.105517. Epub 2021 Sep 21. Oral Oncol. 2021. PMID: 34560383 Clinical Trial.
14 results